Hokuto Morita, MD
Neurology · Chapel Hill
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · University of North Carolina at Chapel Hill · 2,028 clinicians in this group
Looking this up.
Hospitals listed: Rex Hospital · Unc Hospitals. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Morita’s office at (984) 974-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A139251 · Delinquent
Licence status: Delinquent · since 2015 · expires 2023-01-31 · Pennsylvania State University College of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Rex HospitalRaleigh, NCAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of UNC Health Care System, which runs 15 hospitalsPatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.39 (0.94 to 1.83) · 12,134 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.3, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.272, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.474, Oct 2024 – Sep 2025
- Unc HospitalsChapel Hill, NCAcute Care Hospital · Government - State · Has an emergency department · Birthing-friendlyPart of UNC Health Care System, which runs 15 hospitalsHome of UNC Lineberger Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.685, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.606, Oct 2024 – Sep 2025
See every measure and the patient survey for Rex Hospital
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.39 (0.94 to 1.83) · 12,134 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.3 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.272 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.474 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.62 (0 to 1.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.19 (0.99 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.96 (121.13 to 196.78) · 202 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 246 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 183 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.2 · 1,092 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 713 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 574 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 8,820 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.11 to 0.41) · 14,264 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.11 to 0.45) · 15,123 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.62 (2.12 to 5.11) · 4,718 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.48 (0.37 to 2.59) · 2,227 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.44 (1.33 to 3.54) · 4,449 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.28 (6.6 to 13.96) · 2,145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.14 (1.69 to 6.6) · 2,121 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.35 (0.01 to 2.69) · 1,045 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 164 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.824 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.816 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.453 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 844 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,888 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -11.9 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.2 · 1,262 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.6 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 1,167 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.5 (5.1 to 8.3) · 629 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.5 (7.7 to 11.6) · 629 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 159 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.2 · 349 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 372 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.7 (11.6 to 18.8) · 1,010 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (1 to 1.3) · 2,446 cases | No different | Jan 2024 – Dec 2024 |
What patients said (5,160 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Unc Hospitals
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 5 better, 6 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.685 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.606 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.77 (0.02 to 1.52) · 2,693 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.71 to 1.12) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 161.89 (128.51 to 195.27) · 264 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 408 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.1 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 493 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,907 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.13 to 0.49) · 10,696 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.15 to 0.5) · 11,495 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.29 (1.79 to 4.79) · 3,768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.04 (0 to 2.24) · 1,925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (1.06 to 3.17) · 3,512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.88 (4.9 to 12.87) · 1,760 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.44 (1.13 to 5.76) · 1,918 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.52 (0.22 to 2.82) · 1,003 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.29 to 1.12) · 9,900 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 189 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.018 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.697 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.637 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.796 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 399 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.8 · 897 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -10.4 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.4 · 451 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.8 · 428 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 14.5 · 698 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.8 (4.6 to 7.2) · 922 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (8.2 to 11.7) · 922 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.6 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.9 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 334 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.4 to 13.9) · 2,091 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,351 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,558 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$39,344
Medicare paid this office $39,344 for 328 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 132 | $10,479 | $62 |
| New patient visit (60+ min) | 58 | $7,318 | $126 |
| Long return visit (40+ min) | 64 | $6,778 | $101 |
| New patient visit (45+ min) | 49 | $4,609 | $94 |
| Short return visit (20+ min) | 46 | $2,785 | $53 |
See all 8 services
| Return visit (30+ min) | 132 | $10,479 | $62 |
| New patient visit (60+ min) | 58 | $7,318 | $126 |
| Long return visit (40+ min) | 64 | $6,778 | $101 |
| New patient visit (45+ min) | 49 | $4,609 | $94 |
| Short return visit (20+ min) | 46 | $2,785 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,117 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,588 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,452 | $97 |
Who their Medicare patients are
328 Original Medicare patients in 2024. Average age 74 · Under 65 9% · 85 and older 7% · Women 48% · Also on Medicaid 9% · Health risk score 1.63. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Depression 39% · Diabetes 30% · Coronary heart disease 29% · Chronic kidney disease 22% · Dementia 21% · Atrial fibrillation 19% · Cancer 17% · COPD 17% · Stroke 17% · Heart failure 16%.
The office billed $167,818, Medicare allowed $53,360 and paid $39,344; for 496 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 328 | 496 | 74 | 1.63 | $167,818 | $39,344 |
| 2023 | 257 | 473 | 73 | 1.76 | $136,645 | $33,181 |
| 2022 | 213 | 388 | 72 | 1.91 | $112,943 | $29,669 |
| 2021 | 310 | 357 | 74 | 1.50 | $80,046 | $14,699 |
| 2020 | 431 | 847 | 74 | 1.52 | $190,616 | $44,403 |
| 2019 | 506 | 1,011 | 73 | 1.53 | $117,571 | $68,310 |
| 2018 | 488 | 875 | 74 | 1.58 | $138,729 | $76,018 |
| 2017 | 412 | 749 | 74 | 1.56 | $185,265 | $71,193 |
| 2016 | 300 | 513 | 74 | 1.39 | $190,474 | $62,098 |
| 2013 | 32 | 42 | 71 | 1.69 | $5,910 | $3,472 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 108 | $11,371 | $73 |
| Short return visit (20+ min) | 90 | $5,475 | $41 |
| Long return visit (40+ min) | 41 | $4,630 | $105 |
| New patient visit (45+ min) | 26 | $2,648 | $102 |
| New patient visit (60+ min) | 20 | $2,564 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,415 | $101 |
| New patient visit (30+ min) | 28 | $1,407 | $50 |
2022: 8 services
| New patient visit (45+ min) | 53 | $5,423 | $102 |
| Short return visit (20+ min) | 70 | $4,680 | $50 |
| Return visit (30+ min) | 45 | $4,233 | $76 |
| Long return visit (40+ min) | 36 | $4,134 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,614 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,470 | $80 |
| New patient visit (30+ min) | 31 | $1,982 | $64 |
| Short return visit | 14 | $621 | $28 |
2021: 4 services
| Short return visit (20+ min) | 151 | $6,466 | $41 |
| Short return visit | 103 | $2,726 | $25 |
| Return visit (30+ min) | 28 | $2,270 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,070 | $40 |
2020: 12 services
| Return visit (30+ min) | 224 | $15,676 | $56 |
| Short return visit (20+ min) | 191 | $11,005 | $46 |
| Long return visit (40+ min) | 32 | $3,469 | $89 |
| New patient visit (45+ min) | 29 | $3,000 | $103 |
| Telephone medical discussion with physician, 11-20 minutes | 39 | $2,013 | $44 |
| New patient visit (30+ min) | 30 | $1,981 | $66 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 13 | $1,661 | $44 |
| Return visit (30+ min) | 17 | $1,230 | $72 |
| Short return visit (20+ min) | 21 | $955 | $45 |
| Short return visit | 37 | $908 | $23 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $431 | $20 |
| Telehealth originating site facility fee | 11 | $235 | $21 |
2019: 6 services
| Return visit (30+ min) | 367 | $39,800 | $63 |
| New patient visit (45+ min) | 85 | $8,699 | $102 |
| Long return visit (40+ min) | 79 | $8,196 | $92 |
| New patient visit (60+ min) | 25 | $3,660 | $146 |
| Short return visit (20+ min) | 43 | $2,591 | $44 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 17 | $2,323 | $44 |
2018: 9 services
| Return visit (30+ min) | 214 | $17,579 | $64 |
| Long return visit (40+ min) | 161 | $16,651 | $84 |
| New patient visit (60+ min) | 67 | $9,380 | $140 |
| New patient visit (45+ min) | 88 | $8,246 | $94 |
| Return visit (30+ min) | 101 | $7,276 | $71 |
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 13 | $5,689 | $158 |
| Long return visit (40+ min) | 45 | $4,354 | $95 |
| New patient visit (45+ min) | 18 | $2,075 | $115 |
| New patient visit (60+ min) | 13 | $1,957 | $151 |
2017: 5 services
| Long return visit (40+ min) | 233 | $32,686 | $91 |
| New patient visit (60+ min) | 87 | $12,070 | $139 |
| Return visit (30+ min) | 139 | $11,378 | $67 |
| New patient visit (45+ min) | 89 | $9,844 | $111 |
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 11 | $4,086 | $163 |
2016: 4 services
| New patient visit (60+ min) | 182 | $27,420 | $151 |
| Long return visit (40+ min) | 156 | $26,063 | $100 |
| New patient visit (45+ min) | 36 | $4,227 | $117 |
| Electronic analysis and programming of implanted complex deep brain neurostimulator generator system, first hour | 11 | $3,540 | $161 |
2013: 1 service
| New patient visit (45+ min) | 15 | $1,626 | $108 |
Medicaid work
$5,425 in 2024
Medicaid paid $5,425 for 114 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital outpatient clinic visit for assessment and management of a patient | 98 | $4,923 |
| Return visit (30+ min) | 16 | $502 |
| 2024 | 114 | 2 | 21 | $5,425 |
| 2023 | 136 | 3 | 26 | $4,570 |
| 2022 | 46 | 2 | 17 | $1,112 |
| 2020 | 12 | 1 | 12 | $356 |
| 2019 | 95 | 1 | 16 | $2,749 |
| 2018 | 25 | 1 | 13 | $720 |
See the largest Medicaid services in earlier years
2023
| Hospital outpatient clinic visit for assessment and management of a patient | 107 | $3,819 |
| Return visit (30+ min) | 15 | $566 |
| Short return visit (20+ min) | 14 | $185 |
2022
| Hospital outpatient clinic visit for assessment and management of a patient | 30 | $927 |
| Short return visit (20+ min) | 16 | $185 |
2020
| Return visit (30+ min) | 12 | $356 |
2019
| Return visit (30+ min) | 95 | $2,749 |
2018
| Return visit (30+ min) | 25 | $720 |
Drugs they prescribed that Part D paid
$278,133
Pharmacies billed $278,133 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,237 generic and 107 brand-name prescriptions · $278,133 in drug cost · 38 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nuplazid | Parkinson's psychosis | 15 | $73,953 | $4,930 |
| Rytary | Parkinson's | 38 | $52,477 | $1,381 |
| Carbidopa-Levodopa | None | 559 | $14,873 | $27 |
| Carbidopa-Levodopa Er | None | 310 | $9,690 | $31 |
| Amantadine | None | 281 | $7,323 | $26 |
See all 30 drugs
| Nuplazid | Parkinson's psychosis | 15 | $73,953 | $4,930 |
| Rytary | Parkinson's | 38 | $52,477 | $1,381 |
| Carbidopa-Levodopa | None | 559 | $14,873 | $27 |
| Carbidopa-Levodopa Er | None | 310 | $9,690 | $31 |
| Amantadine | None | 281 | $7,323 | $26 |
| Myrbetriq | None | 15 | $6,990 | $466 |
| Carbidopa | None | 21 | $3,051 | $145 |
| Midodrine | None | 16 | $1,961 | $123 |
| Gabapentin | None | 95 | $1,928 | $20 |
| Entacapone | None | 12 | $1,793 | $149 |
| Clonazepam | None | 259 | $1,570 | $6 |
| Primidone | None | 86 | $1,203 | $14 |
| Rivastigmine | None | 16 | $1,047 | $65 |
| Selegiline | None | 15 | $964 | $64 |
| Memantine | None | 56 | $908 | $16 |
| Levetiracetam | None | 46 | $761 | $17 |
| Mirtazapine | None | 41 | $677 | $17 |
| Pramipexole Dihydrochloride | None | 12 | $637 | $53 |
| Propranolol | None | 28 | $588 | $21 |
| Trihexyphenidyl | None | 46 | $487 | $11 |
| Quetiapine | None | 24 | $336 | $14 |
| Donepezil | None | 48 | $312 | $7 |
| Atropine Sulfate | None | 15 | $303 | $20 |
| Trazodone | None | 29 | $243 | $8 |
| Topiramate | None | 37 | $216 | $6 |
| Baclofen | None | 31 | $195 | $6 |
| Ondansetron | None | 16 | $88 | $5 |
| Sertraline | None | 19 | $81 | $4 |
| Pregabalin | None | 12 | $74 | $6 |
| Buspirone | None | 18 | $54 | $3 |
Year by year
| 2024 | 2,344 | 385 | None | 5% | $278,133 |
| 2023 | 1,585 | 267 | None | 5% | $222,393 |
| 2022 | 702 | 189 | None | 2% | $58,544 |
| 2021 | 1,421 | 271 | None | 7% | $376,517 |
| 2020 | 2,438 | 365 | 1% (13) | 7% | $519,455 |
| 2019 | 2,570 | 372 | 1% (15) | 7% | $424,332 |
| 2018 | 2,580 | 376 | 0% (0) | 11% | $422,711 |
| 2017 | 1,685 | 275 | 0% (0) | 7% | $172,270 |
| 2016 | 803 | 183 | None | 3% | $44,093 |
| 2015 | 59 | 19 | 0% (0) | None | $6,713 |
| 2014 | 153 | 45 | None | 15% | $24,179 |
| 2013 | 53 | 20 | 0% (0) | None | $2,680 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Nuplazid | Parkinson's psychosis | 20 | $117,131 | $5,857 |
| Rytary | Parkinson's | 31 | $35,596 | $1,148 |
| Carbidopa-Levodopa | None | 345 | $17,469 | $51 |
| Amantadine | None | 180 | $10,448 | $58 |
| Carbidopa-Levodopa Er | None | 211 | $9,428 | $45 |
| Carbidopa | None | 14 | $2,541 | $181 |
| Rivastigmine | None | 22 | $2,314 | $105 |
| Selegiline | None | 13 | $1,381 | $106 |
| Gabapentin | None | 55 | $1,035 | $19 |
| Levetiracetam | None | 46 | $1,027 | $22 |
| Clonazepam | None | 178 | $987 | $6 |
| Quetiapine | None | 39 | $951 | $24 |
| Primidone | None | 50 | $912 | $18 |
| Memantine | None | 34 | $803 | $24 |
| Mirtazapine | None | 27 | $543 | $20 |
| Propranolol | None | 24 | $478 | $20 |
| Donepezil | None | 42 | $410 | $10 |
| Duloxetine | None | 13 | $285 | $22 |
| Topiramate | None | 27 | $268 | $10 |
| Trihexyphenidyl | None | 28 | $244 | $9 |
| Baclofen | None | 30 | $208 | $7 |
| Trazodone | None | 27 | $188 | $7 |
| Ondansetron | None | 13 | $120 | $9 |
2022: 12 drugs
| Carbidopa-Levodopa | 194 | $11,089 | $57 |
| Carbidopa-Levodopa Er | 109 | $7,311 | $67 |
| Amantadine | 98 | $5,250 | $54 |
| Selegiline | 18 | $1,952 | $108 |
| Levetiracetam | 21 | $509 | $24 |
| Gabapentin | 23 | $509 | $22 |
| Ropinirole | 13 | $429 | $33 |
| Clonazepam | 42 | $371 | $9 |
| Primidone | 20 | $365 | $18 |
| Propranolol | 14 | $326 | $23 |
| Donepezil | 18 | $236 | $13 |
| Mirtazapine | 16 | $165 | $10 |
2021: 22 drugs
| Rytary | Parkinson's | 60 | $134,732 | $2,246 |
| Ingrezza | None | 11 | $74,975 | $6,816 |
| Carbidopa-Levodopa | None | 397 | $41,673 | $105 |
| Carbidopa-Levodopa Er | None | 229 | $33,144 | $145 |
| Neupro | None | 12 | $15,926 | $1,327 |
| Rasagiline Mesylate | None | 32 | $13,881 | $434 |
| Amantadine | None | 94 | $6,982 | $74 |
| Selegiline | None | 20 | $3,889 | $194 |
| Memantine | None | 39 | $3,161 | $81 |
| Primidone | None | 15 | $1,486 | $99 |
| Midodrine | None | 15 | $1,322 | $88 |
| Gabapentin | None | 46 | $1,305 | $28 |
| Fludrocortisone Acetate | None | 14 | $995 | $71 |
| Propranolol | None | 28 | $919 | $33 |
| Mirtazapine | None | 23 | $848 | $37 |
| Baclofen | None | 13 | $797 | $61 |
| Ropinirole | None | 17 | $612 | $36 |
| Levetiracetam | None | 19 | $548 | $29 |
| Donepezil | None | 34 | $546 | $16 |
| Clonazepam | None | 98 | $416 | $4 |
| Topiramate | None | 25 | $244 | $10 |
| Clonidine | None | 29 | $129 | $4 |
2020: 31 drugs
| Rytary | Parkinson's | 109 | $205,543 | $1,886 |
| Carbidopa-Levodopa Er | None | 384 | $51,955 | $135 |
| Carbidopa-Levodopa | None | 601 | $50,902 | $85 |
| Rasagiline Mesylate | None | 40 | $33,246 | $831 |
| Neupro | None | 12 | $23,984 | $1,999 |
| Amantadine | None | 191 | $12,511 | $66 |
| Tetrabenazine | None | 12 | $11,772 | $981 |
| Memantine | None | 93 | $5,754 | $62 |
| Gabapentin | None | 101 | $2,345 | $23 |
| Primidone | None | 34 | $2,192 | $64 |
| Propranolol | None | 55 | $2,189 | $40 |
| Midodrine | None | 25 | $1,806 | $72 |
| Pramipexole Dihydrochloride | None | 16 | $1,709 | $107 |
| Fludrocortisone Acetate | None | 30 | $1,586 | $53 |
| Clonazepam | None | 179 | $1,291 | $7 |
| Mirtazapine | None | 42 | $1,108 | $26 |
| Atropine Sulfate | None | 22 | $1,105 | $50 |
| Donepezil | None | 79 | $1,042 | $13 |
| Baclofen | None | 27 | $927 | $34 |
| Ropinirole | None | 19 | $859 | $45 |
| Trihexyphenidyl | None | 37 | $631 | $17 |
| Propranolol Hcl Er | None | 11 | $630 | $57 |
| Duloxetine | None | 14 | $618 | $44 |
| Levetiracetam | None | 17 | $526 | $31 |
| Quetiapine | None | 16 | $504 | $31 |
| Trazodone | None | 26 | $372 | $14 |
| Topiramate | None | 34 | $371 | $11 |
| Buspirone | None | 13 | $216 | $17 |
| Cyclobenzaprine | None | 13 | $162 | $12 |
| Clonidine | None | 15 | $93 | $6 |
| Tramadol | None | 13 | $23 | $2 |
2019: 35 drugs
| Rytary | Parkinson's | 108 | $167,561 | $1,551 |
| Carbidopa-Levodopa Er | None | 422 | $45,631 | $108 |
| Carbidopa-Levodopa | None | 648 | $42,220 | $65 |
| Xadago | None | 11 | $28,663 | $2,606 |
| Rasagiline Mesylate | None | 37 | $24,801 | $670 |
| Tetrabenazine | None | 12 | $14,148 | $1,179 |
| Neupro | None | 11 | $11,051 | $1,005 |
| Amantadine | None | 118 | $7,844 | $66 |
| Gabapentin | None | 106 | $4,096 | $39 |
| Selegiline | None | 23 | $3,335 | $145 |
| Propranolol | None | 61 | $2,899 | $48 |
| Primidone | None | 55 | $2,652 | $48 |
| Rivastigmine | None | 22 | $1,947 | $89 |
| Memantine | None | 39 | $1,644 | $42 |
| Clonazepam | None | 207 | $1,630 | $8 |
| Pramipexole Dihydrochloride | None | 17 | $1,481 | $87 |
| Ropinirole | None | 35 | $1,422 | $41 |
| Mirtazapine | None | 34 | $1,376 | $40 |
| Midodrine | None | 22 | $962 | $44 |
| Donepezil | None | 86 | $952 | $11 |
| Baclofen | None | 40 | $949 | $24 |
| Levetiracetam | None | 35 | $814 | $23 |
| Fludrocortisone Acetate | None | 30 | $721 | $24 |
| Duloxetine | None | 16 | $672 | $42 |
| Trihexyphenidyl | None | 33 | $518 | $16 |
| Pyridostigmine | None | 15 | $495 | $33 |
| Topiramate | None | 46 | $358 | $8 |
| Divalproex | None | 23 | $357 | $16 |
| Trazodone | None | 32 | $349 | $11 |
| Escitalopram | None | 15 | $193 | $13 |
| Cyclobenzaprine | None | 25 | $186 | $7 |
| Citalopram Hbr | None | 12 | $92 | $8 |
| Clonidine | None | 12 | $73 | $6 |
| Lorazepam | None | 13 | $32 | $2 |
| Tramadol | None | 15 | $23 | $2 |
2018: 32 drugs
| Rytary | Parkinson's | 117 | $128,011 | $1,094 |
| Carbidopa-Levodopa | None | 728 | $40,971 | $56 |
| Rasagiline Mesylate | None | 37 | $33,147 | $896 |
| Carbidopa-Levodopa Er | None | 324 | $27,786 | $86 |
| Xadago | None | 22 | $24,875 | $1,131 |
| Myrbetriq | None | 36 | $15,893 | $441 |
| Neupro | None | 16 | $14,717 | $920 |
| Azilect | None | 11 | $10,468 | $952 |
| Amantadine | None | 83 | $7,993 | $96 |
| Carbidopa | None | 11 | $5,841 | $531 |
| Gabapentin | None | 172 | $4,523 | $26 |
| Selegiline | None | 29 | $4,104 | $142 |
| Ropinirole Er | None | 12 | $3,560 | $297 |
| Propranolol | None | 101 | $2,761 | $27 |
| Pramipexole Dihydrochloride | None | 22 | $2,442 | $111 |
| Atropine Sulfate | None | 30 | $2,202 | $73 |
| Propranolol Hcl Er | None | 14 | $2,041 | $146 |
| Primidone | None | 64 | $1,851 | $29 |
| Midodrine | None | 12 | $1,559 | $130 |
| Mirtazapine | None | 48 | $1,495 | $31 |
| Clonazepam | None | 186 | $1,456 | $8 |
| Ropinirole | None | 28 | $847 | $30 |
| Duloxetine | None | 12 | $600 | $50 |
| Donepezil | None | 58 | $566 | $10 |
| Topiramate | None | 60 | $532 | $9 |
| Levetiracetam | None | 31 | $527 | $17 |
| Baclofen | None | 39 | $509 | $13 |
| Trihexyphenidyl | None | 36 | $398 | $11 |
| Quetiapine | None | 21 | $358 | $17 |
| Fludrocortisone Acetate | None | 13 | $278 | $21 |
| Escitalopram | None | 34 | $255 | $7 |
| Clonidine | None | 13 | $94 | $7 |
2017: 26 drugs
| Rytary | Parkinson's | 36 | $47,961 | $1,332 |
| Carbidopa-Levodopa | None | 642 | $31,156 | $49 |
| Carbidopa-Levodopa Er | None | 209 | $15,792 | $76 |
| Azilect | None | 11 | $7,737 | $703 |
| Rivastigmine | None | 13 | $3,973 | $306 |
| Fluoxetine | None | 19 | $2,461 | $130 |
| Amantadine | None | 23 | $1,922 | $84 |
| Selegiline | None | 20 | $1,864 | $93 |
| Gabapentin | None | 107 | $1,779 | $17 |
| Atropine Sulfate | None | 22 | $1,331 | $60 |
| Propranolol | None | 41 | $1,276 | $31 |
| Trospium Chloride | None | 15 | $1,037 | $69 |
| Clonazepam | None | 141 | $883 | $6 |
| Primidone | None | 33 | $574 | $17 |
| Quetiapine | None | 19 | $468 | $25 |
| Ropinirole | None | 19 | $436 | $23 |
| Mirtazapine | None | 11 | $373 | $34 |
| Trihexyphenidyl | None | 23 | $299 | $13 |
| Donepezil | None | 33 | $260 | $8 |
| Levetiracetam | None | 21 | $231 | $11 |
| Topiramate | None | 37 | $220 | $6 |
| Pramipexole Dihydrochloride | None | 13 | $189 | $15 |
| Citalopram Hbr | None | 12 | $172 | $14 |
| Baclofen | None | 11 | $152 | $14 |
| Escitalopram | None | 15 | $147 | $10 |
| Sertraline | None | 15 | $45 | $3 |
2016: 9 drugs
| Rytary | Parkinson's | 15 | $13,207 | $880 |
| Carbidopa-Levodopa | None | 370 | $12,460 | $34 |
| Carbidopa-Levodopa Er | None | 103 | $6,275 | $61 |
| Propranolol | None | 31 | $1,213 | $39 |
| Primidone | None | 33 | $694 | $21 |
| Clonazepam | None | 80 | $603 | $8 |
| Gabapentin | None | 38 | $500 | $13 |
| Trihexyphenidyl | None | 16 | $128 | $8 |
| Topiramate | None | 11 | $91 | $8 |
2015: 1 drug
| Carbidopa-Levodopa | 18 | $873 | $49 |
2014: 4 drugs
| Azilect | 23 | $16,735 | $728 |
| Carbidopa-Levodopa | 54 | $3,669 | $68 |
| Clonazepam | 16 | $160 | $10 |
| Primidone | 12 | $101 | $8 |
2013: 2 drugs
| Carbidopa-Levodopa | 11 | $1,093 | $99 |
| Simvastatin | 11 | $106 | $10 |
Professional record
- NPI
- 1396970760
- Licence
- CA A139251, MN 105054, MN 53412, PA MT195347California A139251: Delinquent · expires 2023-01-31
- Trained
- Pennsylvania State University College of Medicine, 2009
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X); Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-05-28
- NPI last updated
- 2015-11-19
This is when the NPI record was last certified, not a medical board exam.